Minerva Neurosciences Inc.
NERV | NASDAQ
$3.69
+$0.03 (+0.82%)
At close: Sep 21, 2026, 4:00 PM ET
$3.70
+$0.01 (+0.27%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Market Data
Market Cap $171.68M
Enterprise Value $-75.1B
Beta -0.11
Average Volume 218.34K
Shares Outstanding (Diluted) 79.11M
Shares Change YoY 945.12%
Institutional Ownership 87.24%
Exchange NASDAQ
ISIN US6033802058
Price Performance
Price Change 1M -23.0%
Price Change 3M -15.2%
Price Change 6M -39.5%
Price Change YTD -5.9%
Price Change 1Y 77.4%
Price Change 3Y -52.1%
Price Change 5Y -77.4%
1M CAGR (ann.) -13.6%
1Y CAGR (ann.) 79.1%
5Y CAGR (ann.) -23.1%
All-Time CAGR -19.0%
Valuation
PE Ratio -0.13
Forward PE N/A
PEG Ratio -0.00
Forward PEG 0.00
PS Ratio N/A
Forward PS 3.00
PB Ratio -0.00
P/FCF Ratio -0.01
P/Adj. FCF Ratio -0.01
P/OCF Ratio -0.01
EV/Sales N/A
EV/EBIT 182.35
EV/EBITDA 6.79
EV/FCF 4.00
Earnings Yield -782.4%
FCF Yield -10938.6%
Adj. FCF Yield -17336.2%
Financial Health
Net Cash $75.27B
Total Debt $0
Cash & Short-Term Investments $75.27B
Total Assets $95.09B
Current Ratio 20.14
Quick Ratio 20.14
Debt / Equity Ratio 0.00
Debt / EBITDA -0.00
Debt / FCF -0.00
OCF / Debt N/A
Interest Coverage 0.00
Altman Z-Score -11.74
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) -58.5%
Returns
Return on Assets -414.7%
Return on Equity 250.0%
Return on Invested Capital -38.6%
Return on Capital Employed -38.6%
Return on Tangible Assets -491.6%
Historical Growth (CAGR)
Revenue CAGR 3Y N/A
Revenue CAGR 5Y N/A
Revenue CAGR 10Y -18.2%
EPS CAGR 3Y -115.1%
EPS CAGR 5Y -35.3%
EPS CAGR 10Y -6.3%
FCF CAGR 3Y -149.6%
FCF CAGR 5Y -99.4%
FCF CAGR 10Y -53.8%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 7
EPS Growth Next 3Y 32.8%
Revenue Growth Next 3Y N/A
Earnings Date Nov 3, 2026
EPS Estimate (next Q) -$0.14
EPS Growth Est (next Q) -61.1%
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $10
Price Target Upside 171.0%
Cash Flow
Operating Cash Flow $-18.78B
Free Cash Flow $-18.78B
Adj. Free Cash Flow $-29.76B
FCF Per Share -$403
OCF Per Share -$403
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $0
Operating Income $-10.67B
EBITDA $-11.05B
Net Income $16.24B
EPS (Diluted) -$28.87
Revenue / Employee N/A
Profit / Employee $2.32B
Employees 7
Add to Watchlist
Select watchlists to add or remove NERV